Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE
Kakkis Emil D received 76,745 Ultragenyx Pharmaceutical Inc. shares as an award (Form 4)
Traded Apr 16, 2026 · Filed Apr 20, 2026
On Apr 16, 2026, Kakkis Emil D (Director, President & CEO) received 76,745 Ultragenyx Pharmaceutical Inc. shares as an award, leaving 735,739 shares. Filed Apr 20, 2026 (Form 4).
- Awarded
- 76,745 shares
- Holding after
- 735,739 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | Award | 76,745 | 735,739 | Direct |
Source
Related
- Ultragenyx Pharmaceutical Inc.
- Kakkis Emil D
- Ultragenyx Pharmaceutical Inc. shareholders
- Schedule 13G · Madison Avenue Partners, LP · Oct 20, 2026
- Form 4 · Horn Howard · Oct 19, 2026
- Form 4 · Huizenga Theodore Alan · Sep 15, 2026
- Form 4 · Huizenga Theodore Alan · Sep 8, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026